MarketInOut Stock Screener Log In | Sign Up

Nectar Lifesciences Ltd

BSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/27/2026 15:50
Nectar Lifesciences Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeBSE
Market Capitalization2,006.72 mln
Float89.44 mln

Piotroski F-Score

4 / 9
Borderline

Relative Strength

89 / 100
Strongly outperforming

Debt / Equity

0.79
Moderate leverage

Pre-Tax Margin

-342%
Severely loss-making

ROE

-32.60
Deeply negative

Altman Z-Score

4.35
Strong

Business Description

Nectar Lifesciences Limited is an India-based pharmaceutical company founded in 1995 and headquartered in Chandigarh, with operations serving both domestic and international markets. The company specializes in producing a broad range of cephalosporin antibiotics, including active ingredients, intermediates, and finished forms such as tablets, capsules, oral suspensions, and injectables. It also offers contract manufacturing services to other pharmaceutical firms and produces menthol and pearl capsules.

Key Fundamentals

EPS-2.08
ROE-32.60
RPS74.60
ROA-16.40
Interest Cover-2.40
EBITDA, mln113
EV / EBITDA7.90
EV / EBIT8.24
Revenue, mln74.43
EV / Revenue11.98

Quote Details

Last 10.60
Change 0.11 (1.05%)
Open 10.47
Volume 14,185
Turnover 150,361
Average Volume 25,896

Financial Ratios

Pre-Tax Profit Margin-342
Current Ratio9.71
Price / Book0.35
Price / Tangible Book0.35
Price / Cash Flow1.31
Price / Free Cash Flow1.39
Debt / Equity0.79
Price / Sales30.27

Financial Strength

Altman Z-Score4.35
Piotroski F-Score 4 / 9
Price to Intrinsic Value1.26

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -4.25% 44 / 100   
1 Month -2.57% 70 / 100   
2 Months -3.2% 63 / 100   
6 Months -9.79% 45 / 100   
1 Year -23.02% 43 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog